Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer in the Elderly Full Text
Journal of Clinical Oncology,

Cuffe S et al. – Uptake of adjuvant chemotherapy for non–small–cell lung cancer (NSCLC) increased in patients age 70years or older following reporting of pivotal adjuvant chemotherapy trials, but it remained below that for patients younger than age 70years. Adoption of adjuvant chemotherapy appears to be associated with significant survival benefit in the elderly (age ≥70years), with tolerability apparently similar to that of patients who are younger than age 70years.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close